APW
NVAX icon

Aventura Private Wealth’s Novavax NVAX Stock Holding History

Aventura Private Wealth’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$1.73K – 891
2025
Q3 		$1.73K Hold
200
– – ﹤0.01% 691
2025
Q2 		$1.26K Hold
200
– – ﹤0.01% 674
2025
Q1 		$1.28K Hold
200
– – ﹤0.01% 636
2024
Q4 		$1.61K Buy
+200
New +$1.93K ﹤0.01% 600

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aventura Private Wealth's NVAX Position: Q4 2025 in Review

Aventura Private Wealth sold out of Novavax (NVAX) in Q4 2025, closing a stake of 200 shares — an estimated $1.73K sold.

Aventura Private Wealth first reported a position in NVAX in Q4 2024 and held it in 4 quarters. The position peaked at $1.73K in Q3 2025. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Aventura Private Wealth reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • Aventura Private Wealth sold 200 Novavax shares in Q4 2025, an estimated $1.73K.
  • Aventura Private Wealth first reported a position in Novavax in Q4 2024 and held it in 4 quarters.
  • Aventura Private Wealth's Novavax position peaked at $1.73K in Q3 2025.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Aventura Private Wealth's 13F filing for Q4 2025, filed 7 Jan 2026.